BackCan-Fite Biopharma Overview

Can-Fite Biopharma Total Revenue

Revenue analysis for CANF.

Quarterly Revenue

$101000.00
↓ 36.08% YoY

As of Jun 2025

Annual Revenue (TTM)

$560000.00
↓ 16.04% YoY

Trailing 12 months ending Jun 2025

Average Revenue (Comparison Companies)

Loading

Total Revenue History

Loading

Total Revenue Comparison

Loading

Annual Revenue Growth Rate (%)

Loading

Annual Revenue Growth (Absolute)

Loading
Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin